| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Werner Milton H. serves as a President And CEO at IKT. Across recent SEC filings that breaks down to 8 buys and 0 sells. Those positions are worth an estimated $13.2M at current prices.
Historically, Werner Milton H.'s trades have earned a below-average insider score of 24/100 across 4 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -38.7%.
The biggest single holding is IKT (~$13.2M) as President And CEO. Net of sales, the recent Form 4 record there shows accumulation of 43,589 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | IKT Inhibikase Therapeutics, Inc. | President And CEO | Buy | 5,000 | $0.80 | $4,000.00 | - | -32.3% | -53.2% | |
| May 27, 2022 | IKT Inhibikase Therapeutics, Inc. | President And CEO | Buy | 5,000 | $0.98 | $4,880.00 | - | -6.0% | -34.2% | |
| May 20, 2022 | IKT Inhibikase Therapeutics, Inc. | President And CEO | Buy | 10,000 | $0.60 | $6,000.00 | +0.2% | +22.2% | -2.5% | |
| Nov 17, 2021 | IKT Inhibikase Therapeutics, Inc. | President And CEO | Buy | 23,589 | $1.97 | $46,558.14 | +25.0% | -37.4% | -64.9% |